Llopis, Marta

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice

Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., et al. (2013) · Gut

Gut microbiota and healthLiver Disease Diagnosis and Treatment

Cited by 1,001

The Gut Microbiota Predispose to the Pathophysiology of Acute Postradiotherapy Diarrhea

Manichanh, C., Varela, E., Martinez, C., Antolin, M., Llopis, M., Dor, J., Giralt, J., Guarner, F., & Malagelada, J.-R. (2008) · The American Journal of Gastroenterology

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 201

Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial

Pose, E., Napoleone, L., Amin, A., Campion, D., Jimenez, C., Piano, S., Roux, O., Uschner, F. E., de Wit, K., Zaccherini, G., et al. (2020) · The Lancet Gastroenterology & Hepatology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 154